Correlation Between Alterola Biotech and Cipher Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alterola Biotech and Cipher Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alterola Biotech and Cipher Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alterola Biotech and Cipher Pharmaceuticals, you can compare the effects of market volatilities on Alterola Biotech and Cipher Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alterola Biotech with a short position of Cipher Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alterola Biotech and Cipher Pharmaceuticals.
Diversification Opportunities for Alterola Biotech and Cipher Pharmaceuticals
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Alterola and Cipher is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Alterola Biotech and Cipher Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cipher Pharmaceuticals and Alterola Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alterola Biotech are associated (or correlated) with Cipher Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cipher Pharmaceuticals has no effect on the direction of Alterola Biotech i.e., Alterola Biotech and Cipher Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alterola Biotech and Cipher Pharmaceuticals
If you would invest 0.52 in Alterola Biotech on August 29, 2024 and sell it today you would lose (0.02) from holding Alterola Biotech or give up 3.85% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 4.55% |
| Values | Daily Returns |
Alterola Biotech vs. Cipher Pharmaceuticals
Performance |
| Timeline |
| Alterola Biotech |
| Cipher Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Alterola Biotech and Cipher Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alterola Biotech and Cipher Pharmaceuticals
The main advantage of trading using opposite Alterola Biotech and Cipher Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alterola Biotech position performs unexpectedly, Cipher Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cipher Pharmaceuticals will offset losses from the drop in Cipher Pharmaceuticals' long position.| Alterola Biotech vs. Amexdrug | Alterola Biotech vs. Aion Therapeutic | Alterola Biotech vs. Antisense Therapeutics Limited | Alterola Biotech vs. The BC Bud |
| Cipher Pharmaceuticals vs. Bionoid Pharma | Cipher Pharmaceuticals vs. Centr Brands Corp | Cipher Pharmaceuticals vs. CTT Pharmaceutical Holdings | Cipher Pharmaceuticals vs. Alterola Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |